4/A//SEC Filing
McLaughlin Gerald W. 4/A
Accession 0001437749-25-001850
CIK 0001860657other
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 8:07 PM ET
Size
5.4 KB
Accession
0001437749-25-001850
Insider Transaction Report
Form 4/AAmended
McLaughlin Gerald W.
Director
Transactions
- Award
Stock Options
2025-01-22+25,000→ 25,000 totalExercise: $1.01From: 2025-01-22Exp: 2035-01-22→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The stock options, granted on January 22, 2025 pursuant to Allarity Therapeutics, Inc.'s Amended and Restated 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the anniversay of the grant and are exercisable beginning as of that date.
Documents
Issuer
Allarity Therapeutics, Inc.
CIK 0001860657
Entity typeother
Related Parties
1- filerCIK 0001495412
Filing Metadata
- Form type
- 4/A
- Filed
- Jan 23, 7:00 PM ET
- Accepted
- Jan 24, 8:07 PM ET
- Size
- 5.4 KB